Integrated profiling identifies caveolae-associated protein 1 as a prognostic biomarker of malignancy in glioblastoma patients.

CONCLUSIONS: We identified CAVIN1 as a prognostic biomarker and potential target for developing novel therapeutic strategies against GBM. PMID: 30311408 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30311408?dopt=Abstract

Source: CNS Neuroscience and Therapeutics - October 11, 2018 Category: Neuroscience Authors: Guo Q, Guan GF, Cheng W, Zou CY, Zhu C, Cheng P, Wu AH Tags: CNS Neurosci Ther Source Type: research